Drug testing and drug demand reduction program

Ended Awarded Last action

Contract number
HQ003424F0601
Awardee
Awarding agency
Obligated
$6,089,673

Award facts

Opportunity
  • HQ003422R0179 Solicitation number
Contract value 100% obligated
$6,089,672.87 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Bureau of Medicine and Surgery Department of the Navy, Department of Defense
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Portsmouth, VA 23708, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · Drug testing, drug demand reduction program $0
Original award $6,089,673

About this award

This is a firm fixed-price contract awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Agilent Technologies Inc. for a Drug Testing and Drug Demand Reduction Program. The contract has a ceiling value of $6,089,672.87 and an ultimate completion date of September 8, 2025. The contract was awarded on September 6, 2024 and is a Blanket Purchase Agreement (BPA) call. No small business set-aside was used.

Agilent Technologies Inc., a global leader in life sciences and analytical instrumentation, will provide specialized laboratory equipment and services to support the Bureau of Medicine and Surgery's drug testing and demand reduction initiatives. This includes the procurement, maintenance, and repair of advanced scientific instruments such as liquid chromatography-mass spectrometry systems, gas chromatography-mass spectrometry equipment, and other analytical tools. The parent company, Agilent Technologies, Inc., has a significant federal contracting presence, delivering high-precision analytical technologies and services across numerous government agencies.

Quick answers

Who was awarded contract HQ003424F0601?

HQ003424F0601 was awarded to Agilent Technologies Inc. by Washington Headquarters Service (Department of Defense) on September 6, 2024.

How much is contract HQ003424F0601 worth?

The government has obligated $6,089,673 on HQ003424F0601.

Which agency awarded contract HQ003424F0601?

Washington Headquarters Service (Department of Defense) awarded HQ003424F0601, with funding from Bureau of Medicine and Surgery (Department of the Navy).

Is contract HQ003424F0601 an order under another contract?

Yes. HQ003424F0601 is a BPA call under HQ003422A0015, a blanket purchase agreement.

Was contract HQ003424F0601 competed?

The extent of competition for HQ003424F0601 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award